Neurizon Therapeutics Limited: HEALEY ALS Platform Trial Regimen I enrolment completed - Topline results for NUZ-001 accelerated to Q2 CY2027

HEALEY ALS Platform Trial so far Anticipated topline efficacy and safety results for NUZ-001 now expected in late Q2 CY2027 Completion of recruitment materially de-risks execution of Neurizon's lead ...

Bonava AB: Bonava's interim report for the second quarter of 2026: Improved profitability with controlled growth

Net sales amounted to SEK 2,090 M (1,839) Gross margin amounted to 15.5 per cent (13.0) EBIT amounted to SEK 166 M (78) and EBIT margin was 7.9 per cent (4.3) Net ...

Elutia Inc.: Elutia Signs Definitive Agreement to Sell SimpliDerm in Transaction Valued at up to $11 Million, Strengthening Balance Sheet Ahead of NXT-41x Launch

Transaction provides $8 million in cash at closing and up to $3 million in technology transfer and commercial milestone payments over the next 18 monthsProceeds provide additional non-dilutive capital ...

Lindab AB: Lindab Group's Interim Report January-June 2026: Organic growth, but inflation pressured margins

PRESS RELEASE 17 July 2026 The Group reported organic growth in the second quarter of the year. Operating profit, however, was held back by higher costs for input material and transportation following ...

Alligo AB: Interim Report Q2 2026 - Continued organic growth, increased profit and improved cash flow

Second quarter 2026 highlightsRevenue increased by 5.7 per cent to MSEK 2,611 (2,470). Organic growth was 1.3 per cent.Gross margin was 40.7 per cent (40.1).Adjusted EBITA increased to MSEK 187 (144), ...

Wise Group plc reports Q1 FY27 Results

Wise Group plc (Nasdaq: WSE; LSE: WISE), the global technology company building the best way to move and manage the world's money, today announces its Q1 FY27 ...

Jasper Therapeutics, Inc. Announces Merger with Kira Pharmaceuticals

Combined company positioned to advance portfolio of biologic agents designed to improve outcomes in patients with numerous immunologically-driven disorders Concurrent $132 million private investment w ...

Lindex Group Oyj: Lindex Group's Half-year Financial Report 1 January-30 June 2026

Lindex Group delivered strong adjusted operating result and revenue growth during the second quarter LINDEX GROUP plc, Half-year financial report 17.7.2026 at 8:30 EESTLindex Group's Half-year Financi ...

Cint Group AB: Cint has applied for delisting of its shares from Nasdaq Stockholm

On 27 April 2026, a bid consortium today consisting of Triton Fund 6 and Bolero Holdings SARL, acting through TriCarbs BidCo AB, (the "Bidder") announced a public cash offer (the "Offer") to the share ...

Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period

Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply ...

Perseus Mining Limited: Perseus Mining Pursues Growth Opportunities at Yaoure Gold Mine

PERSEUS MINING PURSUES VALUE CREATING ORGANIC GROWTH OPPORTUNITES AT THE YAOURE GOLD MINE Perth, Western Australia/July 17, 2026/Perseus Mining Limited (ASX/TSX: ...

SiriusPoint Ltd.: SiriusPoint Appoints Emily Yoo as Chief Operating Officer

SiriusPoint Ltd. ("SiriusPoint" or the "Company") (NYSE: SPNT), a global specialty underwriter, today announced the appointment of Emily Yoo as Chief ...